Related Experiment Video
Updated: Aug 23, 2025

10:28
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
Published on: March 9, 2017
9.0K
Engineering cell fate: Applying synthetic biology to cellular reprogramming.
Nathan B Wang1, Adam M Beitz1, Kate E Galloway1
1Department of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA, 02139, USA.
Current Opinion in Systems Biology
|November 4, 2022
Summary
Synthetic biology advances cellular reprogramming by overcoming key challenges like factor delivery and epigenetic barriers. This improves the efficiency and maturity of in vitro cell models for disease research.
Area of Science:
- Cellular and Molecular Biology
- Synthetic Biology
- Biotechnology
Background:
- Cellular reprogramming creates new cell fates, transforming disease modeling.
- In vitro cell models derived from reprogramming face limitations in efficiency and maturity.
- Understanding reprogramming mechanisms is crucial for advancing cell-based research.
Purpose of the Study:
- To review recent advancements in cellular reprogramming driven by synthetic biology.
- To highlight how synthetic biology addresses key challenges in reprogramming.
- To explore the role of molecular systems biology in enhancing reprogramming.
Main Methods:
- Deployment of synthetic biology tools to overcome reprogramming limitations.
- Targeting challenges such as reprogramming factor delivery, epigenetic roadblocks, and donor identity.
- Leveraging insights from molecular systems biology to engineer cell fate.
Main Results:
- Synthetic biology approaches have significantly improved reprogramming efficiency and cell model maturity.
- Novel tools address specific barriers, enabling broader applications of cellular reprogramming.
- Systems-level understanding facilitates the development of advanced reprogramming technologies.
Conclusions:
- Synthetic biology is pivotal in overcoming major hurdles in cellular reprogramming.
- Enhanced reprogramming technologies are crucial for advancing in vitro disease modeling.
- New synthetic biology tools offer powerful strategies for engineering cell fate and function.
Keywords:
BarcodingCell fateCell stateCellular reprogrammingDeliveryEpigeneticsGene circuitsGene regulatory networksLatent donor identityLineage tracingSignalingSynthetic biologyMore Related Videos
Related Concept Videos
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
Chromatin Modification in iPS Cells
1.8K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.8K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K

